Mark Gordon, MS, RAC, FRAPS
Chief Regulatory Officer
Mark Gordon joined Outset as Chief Regulatory Officer in October 2022, where he is leading the company’s global regulatory strategy. With more than 40 years of experience in private and publicly held medical device companies, Mark’s most recent position was Senior Vice President, Regulatory Affairs, at Alcon from 2017 to 2022. Previously, his roles included Vice President, Regulatory Affairs, at Abbott Medical Optics, Vice President, Regulatory and Clinical Affairs, for Synthes, and Vice President, Corporate Regulatory Affairs, at Boston Scientific. He has also served as Vice President, Regulatory Affairs, Clinical Affairs, and/or Quality Assurance at Medtronic and several early-stage organizations.
Mark has served as a member of the Board of Directors of National Alliance for Eye and Vision Research, as Chairman of the Regulatory Affairs Professional Society (RAPS) Board of Directors, and roles with the MDMA FDA Strategy Group and the AdvaMed Technology and Regulatory Group.
Mark holds a Bachelor’s and Master’s degree in Bioengineering from the University of California, San Diego.